INTEST CORP (INTT) director receives 12,000-share stock grant

Rhea-AI Filing Summary

DEWS JOSEPH W IV reported acquisition or exercise transactions in this Form 4 filing.

INTEST CORP director Joseph W. Dews IV received an equity award of 12,000 shares of Common Stock on March 16, 2026. The shares were granted at no cash cost per share as compensation, not bought on the open market. After this award, he directly holds 130,250 shares in total.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEWS JOSEPH W IV

(Last) (First) (Middle)

C/O INTEST CORP

804 EAST GATE DR, SUITE 200

(Street)

MT. LAUREL NEW JERSEY 08054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEST CORP [ INTT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		A		12,000	A	$0	130,250	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Duncan Gilmour, Attorney-in-Fact for Joseph W. Dews IV	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did INTT director Joseph W. Dews IV report?

Director Joseph W. Dews IV reported receiving an equity award of 12,000 shares of INTEST CORP Common Stock. The grant was made at $0.00 per share as compensation, increasing his direct holdings to 130,250 shares after the transaction.

Was the INTT insider transaction a market purchase or sale?

The INTT insider transaction was not a market purchase or sale. Joseph W. Dews IV received 12,000 shares as a grant or award at no cash cost, which is typical equity compensation rather than an open-market trade in the company’s stock.

How many INTT shares does Joseph W. Dews IV hold after the grant?

After the reported grant, Joseph W. Dews IV directly holds 130,250 shares of INTEST CORP Common Stock. This total includes the newly awarded 12,000 shares and reflects his direct ownership position following the March 16, 2026 transaction.

What does transaction code “A” mean in the INTT Form 4 filing?

In this INTT Form 4, transaction code “A” indicates a grant, award, or other acquisition of shares. It shows that Joseph W. Dews IV acquired 12,000 shares of Common Stock through an equity award, rather than purchasing them on the open market.

Is the INTT Form 4 transaction by Joseph W. Dews IV considered routine?

The INTT Form 4 reflects a routine equity compensation grant. Joseph W. Dews IV received 12,000 shares at no cost, increasing his direct holdings to 130,250 shares. Such awards are common for directors and do not represent discretionary buying or selling activity.

Does the INTT Form 4 show any derivative securities activity?

No derivative securities activity is shown in this INTT Form 4. The filing reports only a non-derivative Common Stock award of 12,000 shares, and the derivative securities summary section is empty, indicating no options or similar instruments were reported in this transaction.